Clinical Trials Browser

Phase 1/2 × Therapeutics × Other solid neoplasm × Clear all

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult